Literature DB >> 1743211

Small-intestinal abnormalities in cystic fibrosis patients.

E Eggermont1, K De Boeck.   

Abstract

A survey is given of the pathophysiology of the main alterations in the small intestine of cystic fibrosis patients. Special attention is paid to the understanding of meconium ileus in the fetus and the newborn, the repercussion of duodenal acidity on the duodenal mucosa and the intraduodenal digestion, and primary and secondary biochemical alterations in the secretory-digestive-absorptive function of the small-intestinal mucosa. The meconium equivalent syndrome and its connection with the atypical course of intussusception and appendiceal perforation with silent pelvic abscess are also discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1743211     DOI: 10.1007/bf01954999

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  31 in total

1.  LIGHT AND ELECTRON MICROSCOPIC EXAMINATION OF THE SMALL BOWEL OF CHILDREN WITH CYSTIC FIBROSIS.

Authors:  H B FREYE; S M KURTZ; A SPOCK; M P CAPP
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

2.  Enhanced intestinal glucose and alanine transport in cystic fibrosis.

Authors:  P Baxter; J Goldhill; J Hardcastle; P T Hardcastle; C J Taylor
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

3.  Small intestinal permeability and orocaecal transit time in cystic fibrosis.

Authors:  A M Dalzell; N S Freestone; D Billington; D P Heaf
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

4.  Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syncrome.

Authors:  J R Gill; F C Bartter
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

Review 5.  Meconium in health and in disease.

Authors:  I Antonowicz; H Shwachman
Journal:  Adv Pediatr       Date:  1979

6.  Fetal abnormalities in cystic fibrosis suggest a deficiency in proteolysis of cholecystokinin.

Authors:  C M Gosden; J R Gosden
Journal:  Lancet       Date:  1984-09-08       Impact factor: 79.321

7.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  [Coprologic anomaly in mucoviscidosis. Presence of albumin in low concentration in the feces].

Authors:  Y Pecau; J Feigelson
Journal:  Arch Fr Pediatr       Date:  1975-10

9.  Prenatal diagnosis of cystic fibrosis by assay of amniotic fluid microvillar enzymes.

Authors:  D J Brock; D Bedgood; C Hayward
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Ileal pH in cystic fibrosis.

Authors:  J Gilbert; J Kelleher; J M Littlewood; D F Evans
Journal:  Scand J Gastroenterol Suppl       Date:  1988
View more
  7 in total

1.  Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.

Authors:  H P Haber; N Benda; G Fitzke; A Lang; M Langenberg; J Riethmüller; M Stern
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 2.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Thomas Kelly; James Buxbaum
Journal:  Dig Dis Sci       Date:  2015-02-04       Impact factor: 3.199

3.  A 3D Polymer Model for Future Nutrition Design Novel Nutrition Approach for Cystic Fibrosis, Ulcerative Colitis and Crohn's Disease.

Authors:  Paul Zarogoulidis; Ioannis Kioumis; Theodora Tsiouda; Nikolaos Pezirkianidis; Christos Ritzoulis; Haidong Huang; Wolfgang Hohenforst-Schmidt; Dionysios Spyratos; Konstantinos Porpodis; Georgia Pitsiou; Sofia Lampaki; John Organtzis; Bianca Kathryn Malecki; Sindre Ervik Saetre; Konstantinos Zarogoulidis; Marek Malecki
Journal:  J Nanomedine Biotherapeutic Discov       Date:  2014-08

4.  Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors:  Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

5.  Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.

Authors:  Dimitra Mitsani; M Hong Nguyen; Ryan K Shields; Yoshiya Toyoda; Eun J Kwak; Fernanda P Silveira; Joseph M Pilewski; Maria M Crespo; Christian Bermudez; Jay K Bhama; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

6.  Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients.

Authors:  Kelong Han; B Capitano; R Bies; B A Potoski; S Husain; S Gilbert; D L Paterson; K McCurry; R Venkataramanan
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

7.  Function and expression of cystic fibrosis transmembrane conductance regulator after small intestinal transplantation in mice.

Authors:  Penghong Song; Wenfeng Song; Xiaosun Liu; Changhai Jin; Haiyang Xie; Lin Zhou; Biguang Tuo; Shusen Zheng
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.